Objectives: Residual airspace following thoracic resections is a common clinical problem. Persistent air leak, prolonged drainage time, and reduced hemostasis extend hospital stay and morbidity. We report a trial of pharmacologic-induced diaphragmatic paralysis through continuous paraphrenic injection of lidocaine to reduced residual airspace. The objectives were confirmation of diaphragmatic paralysis and possible procedure related complications. Methods: Six eligible patients undergoing resectional surgery (lobectomy or bilobectomy) were included. Inclusion criteria consisted of: postoperative predicted FEV1 greater than 1300 ml, right-sided resection, absence of parenchymal lung disease, no class III antiarrhythmic therapy, absence of hypersensitivity reactions to lidocaine, no signs of infection, and informed consent. Upon completion of resection an epidural catheter was attached in the periphrenic tissue on the proximal pericardial surface, externalized through a separate parasternal incision, and connected to a perfusing system injecting lidocaine 1% at a rate of 3 ml/h (30 mg/h). Postoperative ICU surveillance for 24 h and daily measurement of vital signs, drainage output, and bedside spirometry were performed. Within 48 h fluoroscopic confirmation of diaphragmatic paralysis was obtained. The catheter removal coincided with the chest tube removal when no procedural related complications occurred. Results: None of the patients reported respiratory impairment. Diaphragmatic paralysis was documented in all patients. Upon removal of catheter or discontinuation of lidocaine prompt return of diaphragmatic motility was noticed. Two patients showed postoperative hemodynamic irrelevant atrial fibrillation. Conclusion: Postoperative paraphrenic catheter administration of lidocaine to ensure reversible diaphragmatic paralysis is safe and reproducible. Further studies have to assess a benefit in terms of reduction in morbidity, drainage time, and hospital stay, and determine the patients who will profit. #
Introduction
Residual airspace following thoracic surgery is a common problem. Up to 41% of patients undergoing lung resections have residual airspace on conventional radiography on the first postoperative day [1] . 76-90% of these show spontaneous obliteration within 2 days to 12 weeks from surgery [1] [2] [3] . In more extended operations like bilobectomies or combined resections the remaining lung is unable to fill the entire pleural cavity (Fig. 1 ). This may lead to a number of several short-term problems like reduced hemostasis and parenchymal air leak, which can cause more severe complications such as pleural empyema. Depending on their severity, these complications may require reoperations therefore increasing morbidity, mortality, hospital stay, and ultimately health care costs [4] .
Surgical options to prevent residual air space are limited. Since the undersized remaining lung cannot fill the pleural cavity entirely, one possibility is to reduce the intrathoracic volume. The easiest and most often used technique is crushing the phrenic nerve using a surgical clamp. This leads to a paralysis of the diaphragm and consecutively to an elevation, hereby decreasing the intrapleural space. The crushed phrenic nerve theoretically should recover ensuring restoration of diaphragmatic function. However, damage to the nerve may persist possibly causing respiratory problems. Pleural tenting [4, 5] , where a portion of parietal pleura is detached from the endothoracic fascia and placed over the remaining lung ensuring a reduced intrapleural space, is only feasible when the parietal pleura is intact. Any injury to the parietal pleura or extrapleural dissection makes pleural tenting impossible. Other disadvantages include injury to the intercostal nerves and the creation of a large wound after pleural detachment, which may lead to postoperative bleeding. Single intraoperative injection of a local anesthetic, thoracoplasty, pneumoperitoneum, and surgical dissection and reinsertion of the diaphragm on a higher level are rarely used [6] .
We propose a more controllable paralysis of the diaphragm by placing an epidural catheter close to the phrenic nerve during surgery. Continuous injection of lidocaine will temporarily inhibit phrenic nerve function, reducing the volume of the pleural cavity. The objectives of this feasibility study were confirmation of diaphragmatic paralysis and assessment of possible procedure-related complications.
Methods
The present study is a proof of principle study to confirm safe reproducibility of transient diaphragmatic paralysis by periphrenic administration of lidocaine. It is a safe and wellcontrollable drug. The maximum bolus dose of lidocaine for adults is 300 mg (30 ml lidocaine 1%). A subcutaneous bolus injection of 100 mg (10 ml) is followed by a plasma level of 0.5 mg/ml. Toxic effects are usually seen at plasma levels of 8 mg/ml or higher, which is 16-fold higher than the plasma levels reached after a subcutaneous injection of 100 mg. Based on these facts, we established the safe dose of 30 mg/h lidocaine in 1% solution for continuous administration. A plasma accumulation of lidocaine to reach levels with toxic effects can be virtually excluded.
Six eligible patients undergoing resectional surgery (lobectomy, bilobectomy) were included. Inclusion criteria consisted in postoperative predicted forced expiratory volume in 1 s (FEV1) greater than 1300 ml, right-sided resection, absence of parenchymal lung disease, no class III antiarrhythmic therapy, absence of hypersensitivity reactions to Lidocaine, no signs of local or systemic active infection, and informed consent. Informed consent was obtained in writing at least 1 day prior to surgery through the surgeon after careful explanation of the procedure and goals of the study. The study proposal was submitted to the local university ethics commission who granted its approval.
Upon completion of the lung resection, placement of an apical and a posterobasal chest drainage, an epidural catheter was attached in the periphrenic tissue on the proximal pericardial surface, fixed with an absorbable suture (Vicryl Rapid 4-0, Johnson & Johnson Medical, Ethicon Division, CH-8957 Spreitenbach), externalized through a separate incision and connected to a perfusing system injecting Lidocaine 1% at a rate of 3 ml/h (30 mg/h) (Fig. 2) . Application of Lidocaine was started immediately. Perioperative analgesic therapy included the placement of an epidural catheter in all patients. Postoperative intensive care unit surveillance for 24 h and daily measurement of vital signs including blood pressure, heart rate, saturation and hemoglobin values were performed. Drainage output was recorded daily. A bedside spirometry was performed prior to surgery and starting from the first postoperative day every 24 h. Within 48 h from surgery fluoroscopic confirmation of diaphragmatic paralysis was obtained. Daily rounds with the patient included subjective assessment of any respiratory impairment. If no air leakage was detected the apical chest drain was removed within 24 h. The posterobasal drainage was taken away if output was below 300 mL in 24 h. The catheter removal concurred with the removal of the last chest tube when no procedural-related complications occurred or on the 14th postoperative day. Patients were discharged within 1 day after discontinuation of the treatment. Radiologic imaging was obtained to assess proper return of diaphragmatic function. All patients were clinically re-evaluated within 2 weeks after discharge.
Results
Six patients were eligible in an approximate period of 6 months. The patients' characteristics are listed in Table 1 . Four of six patients were diagnosed with non-small cell lung cancer (NSCLC). Two patients had pulmonary metastatic disease from a rectal cancer. Two patients underwent an upper lobectomy, two patients a lower lobectomy, and one patient an upper bilobectomy. The remaining patient with pulmonary metastasis underwent an upper lobectomy and three non-anatomic wedge resections of the remaining two lobes. No patients reported subjective respiratory impairment in the postoperative course. All patients received supplemental oxygen in the first 48 h after surgery (2-4 l/ min). Oxygen saturation was maintained above 90%. Drainage time was on average 8 days (4-18). Three patients had a postoperative air leak; one patient had a prolonged air leak of 18 days. The FEV1 values dropped in average to 54% (45-76%) of the preoperative measurement on the first postoperative day. Before discharge the measurements raised to 67% (42-83%). A similar trend was noted in the measurements of forced vital capacity (FVC). Diaphragmatic paralysis was documented in all patients by fluoroscopy on the second postoperative day (Fig. 3 ). There were no allergic reactions to the catheter-administered local anesthetic. No special instruction for the nurses was needed as a normal perfusing system usually employed with an epidural catheter was used. Initial costs for the catheter system were 15 Euro and the costs for the amount of lidocaine injected per day were approximately 22 Euro. There were no catheter or perfusor malfunctions. Two patients developed atrial fibrillation on the second postoperative day without hemodynamic instability. Lidocaine administration was discontinued for 24 h and therapy with a beta-blocking agent was started. Prompt conversion to normal cardiac rhythm occurred. After readministration of lidocaine no tachyarrhythmia was noted. Residual airspace remained in the patient with prolonged air leak. Upon removal of catheter or discontinuation of lidocaine prompt return of diaphragmatic motility was noticed in the fluoroscopic control (Fig. 3) .
Discussion
Postoperative residual space after lung surgery is a common problem and so far no controlled study reports its occurrence. Avoiding this problem is important because short-term problems such as air leak, persistent large drainage output, and bleeding lead to more serious complications (Fig. 4) . Even if three quarters of the patients with residual air space will show complete reabsorption, 14% will develop complications [1] . An adequate intraoperative dissection strategy can contribute to minimize air leak but a small remaining lung especially after larger resections will not be large enough to fill the pleural cavity. In these cases a small air leak will probably be prolonged. The already mentioned strategies to avoid residual air space such as pneumoperitoneum, pleural tenting, and intraoperative crushing of the phrenic nerve are so far the most frequently used. Iverson et al. reported in 1976 of 50% diminished diaphragmatic function, and 20% permanent diaphragmatic paralysis after crushing the phrenic nerve [7] . There is no controlled data available on this subject. It is therefore surprising that it is widely accepted and even quoted in thoracic surgery textbooks [6, 8] despite a not well-documented rate of permanent diaphragmatic dysfunction. We believe this warrants the avoidance of this technique. Pleural tenting and pneumoperitoneum may reduce the intrapleural space after resection [5] . Pleural tenting is not always feasible and bleeding complications could outweigh the advantages of diminished postoperative airspace. Pneumoperitoneum is reversible, but requires an access to the abdomen either transdiaphragmatically or transabdominally.
Complications associated with pneumoperitoneum, although rare, can be devastating. However, a prospective study did show a reduced drainage time after perioperative institution of pneumoperitoneum [9] . Pleural tenting and pneumoperitoneum require a longer operating time, and even if successful both techniques harbor the potential of severe complications. Sporadic reports of thoracoplasty for managing air space problems are not encouraging [10] . It is a rarely required salvage-type procedure applicable in the late course of complicated persistent pleural space and not suitable for early management of residual air space. In the light of the mentioned shortfalls of the methods used to-date a well reproducible technique, which is fully reversible, is needed. A temporary diaphragmatic paralysis through continuous application of a local anesthetic close to the phrenic nerve is fully reversible and controllable. We demonstrated that a temporary dysfunction of the diaphragm is achieved and well tolerated by the patients. The technique requires only 2 min of additional operating time, is not difficult to perform, and has no added morbidity. Normal diaphragmatic function returns after catheter withdrawal and no procedure-related complications occur. Our results concur with the conclusions in a recent case report where a similar procedure was used to obliterate residual airspace [11] . Although the aim of the study was not evaluation of a better outcome using this technique we observed an unusual long air leak in two patients. Both patients underwent larger resections than standard lobectomy. In both cases unusual tedious intraoperative dissection was encountered because of undeveloped fissures and adhesions. Standard resections will rarely be followed by a persistent air leak. [3] . Obviously only a larger number of patients in a prospective trial can answer the question whether the presented technique will improve outcome in the subgroup of patients undergoing larger resections than lobectomy and especially those presenting with unusual difficult intraoperative dissection. The spirometric data we acquired are not sufficient to state anything about a possible impairment of lung function in addition to the resection. The present study addressed only the feasibility of pharmacologic transient diaphragmatic paralysis. Further prospective evaluation is required to identify the utility in terms of shorter drainage time and lower occurrence of residual airspace-related complications. This would warrant its routine use in the armamentarium of the general thoracic surgeon facing larger lung resections.
Conclusion
Postoperative paraphrenic catheter administration of lidocaine to ensure reversible diaphragmatic paralysis is safe and reproducible. No procedure-related complications were noted. The technique is simple and inexpensive. Further studies have to assess a benefit in terms of reduction in morbidity after lung resection and determine the patients who will profit.
